Keywords: vanguard, discontinues, renal, failure, drug, uk, health

Vanguard Discontinues Renal Failure Drug

Article | 11 December 1998

Print This

UK health care company Vanguard Medica has stopped the development ofVML-252, in trials for elevated phosphate levels in renal failure ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in